This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Rifampicin (chemoprophylaxis in meningococcal disease)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Rifampicin is the most usually used drug for chemoprophylaxis. Typical dose:

  • 600 mg every 12 hours for 2 days - adults and children over 12 years
  • 10 mg/kg in children aged 1-12 years every 12 hours for 2 days
  • 5 mg/kg in children below one year

Chemoprophylaxis is given to close contacts of the patient (household members, kissing contacts, and friends who have stayed in the patient's home for hours during the past week) to eradicate meningococci. In general, 15% of contacts carry meningococci. However only 3-4% of contacts carry the pathogenic strain (1).

Note that the respective summary of product characteristics must be consulted before prescribing any drug mentioned.

Reference:

  • BMJ editorial (1996). Secondary prevention of meningococccal disease. BMJ, 312, 590-1.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page